American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the diagnosis and management of solid pancreatic masses: summary and recommendations.

Autor: Machicado JD; Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan, USA., Sheth SG; Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Chalhoub JM; Division of Gastroenterology and Hepatology, Staten Island University Hospital, Northwell Health, Staten Island, New York, USA., Forbes N; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Desai M; Center for Interventional Gastroenterology at UTHealth, McGovern Medical School, Houston, Texas, USA., Ngamruengphong S; Division of Gastroenterology and Hepatology, Johns Hopkins University, Baltimore, Maryland, USA., Papachristou GI; Division of Gastroenterology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA., Sahai V; Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan, USA., Nassour I; Division of Surgical Oncology, University of Florida, Gainesville, Florida, USA., Abidi W; Section of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas, USA., Alipour O; Division of Gastroenterology, University of Washington Medical Center, Seattle, Washington, USA., Amateau SK; Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota Medical Center, Minneapolis, Minnesota, USA., Coelho-Prabhu N; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA., Cosgrove N; Center for Interventional Endoscopy AdventHealth, Orlando, Florida, USA., Elhanafi SE; Division of Gastroenterology, Texas Tech University Health Sciences Center, El Paso, Texas, USA., Fujii-Lau LL; Department of Gastroenterology, University of Hawaii, Honolulu, Hawaii, USA., Kohli DR; Pancreas and Liver Clinic, Providence Sacred Medical Center, Elon Floyd School of Medicine, Washington State University, Spokane, Washington, USA., Marya NB; Division of Gastroenterology, UMass Chan Medical School, Worcester, Massachusetts, USA., Pawa S; Department of Gastroenterology, Wake Forest School of Medicine, Winston Salem, North Carolina, USA., Ruan W; Division of Pediatric Gastroenterology, Hepatology and Nutrition, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA., Thiruvengadam NR; Division of Gastroenterology and Hepatology, Loma Linda University, Loma Linda, California, USA., Thosani NC; Center for Interventional Gastroenterology at UTHealth, McGovern Medical School, Houston, Texas, USA., Qumseya BJ; Department of Gastroenterology, Hepatology, and Nutrition, University of Florida, Gainesville, Florida, USA.
Jazyk: angličtina
Zdroj: Gastrointestinal endoscopy [Gastrointest Endosc] 2024 Nov; Vol. 100 (5), pp. 786-796. Date of Electronic Publication: 2024 Oct 09.
DOI: 10.1016/j.gie.2024.06.002
Abstrakt: This clinical practice guideline from the American Society for Gastrointestinal Endoscopy (ASGE) provides an evidence-based approach for the role of endoscopy in the diagnosis and management of pancreatic masses. This document was developed using the Grading of Recommendations Assessment, Development and Evaluation framework and addresses needle selection (fine-needle biopsy [FNB] needle vs FNA needle), needle caliber (22-gauge vs 25-gauge needles), FNB needle type (novel or contemporary [fork-tip and Franseen] vs alternative FNB needle designs), and sample processing (rapid on-site evaluation [ROSE] vs no ROSE). In addition, this guideline addresses stent selection (self-expandable metal stents [SEMS] vs plastic stents), SEMS type (covered [cSEMS] vs uncovered [uSEMS]), and pain management (celiac plexus neurolysis [CPN] vs medical analgesic therapy). In patients with solid pancreatic masses undergoing EUS-guided tissue acquisition (EUS-TA), the ASGE recommends FNB needles over FNA needles. With regard to needle caliber, the ASGE suggests 22-gauge over 25-gauge needles. When an FNB needle is used, the ASGE recommends using either a fork-tip or a Franseen needle over alternative FNB needle designs. After a sample has been obtained, the ASGE suggests against the routine use of ROSE in patients undergoing an initial EUS-TA of a solid pancreatic mass. In patients with distal malignant biliary obstruction undergoing drainage with ERCP, the ASGE suggests using SEMS over plastic stents. In patients with proven malignancy undergoing SEMS placement, the ASGE suggests using cSEMS over uSEMS. If malignancy has not been histopathologically confirmed, the ASGE recommends against the use of uSEMS. Finally, in patients with unresectable pancreatic cancer and abdominal pain, the ASGE suggests the use of CPN as an adjunct for the treatment of abdominal pain. This document outlines the process, analyses, and decision approaches used to reach the final recommendations and represents the official ASGE recommendations on the above topics.
Competing Interests: Disclosure The following authors disclosed financial relationships: J. D. Machicado: Consultant for Mauna Kea Technologies, Inc; food and beverage compensation from Mauna Kea Technologies, Inc and Boston Scientific Corporation. S. G. Sheth: Consultant for Janssen Research & Development, LLC. J. M. Chalhoub: Travel compensation from Olympus Corporation of the Americas; food and beverage compensation from Boston Scientific Corporation. N. Forbes: Consultant for Boston Scientific Corporation, Pentax of America, Inc, AstraZeneca, and Pendopharm Inc; speaker for Pentax of America, Inc and Boston Scientific Corporation; research support from Pentax of America, Inc. S. Ngamruengphong: Consultant for Boston Scientific Corporation; food and beverage compensation from Medtronic, Inc, Boston Scientific Corporation, Pentax of America, Inc, and Ambu Inc. G. I. Papachristou: Research support from AbbVie Inc. V. Sahai: Consultant and advisor for AstraZeneca, Autem, Cornerstone, Delcath Systems, GlaxoSmithKline, Helsinn, Histosonics, Ipsen, Incyte, Kinnate, Lynx Group, Servier, and Taiho; research support from Actuate, Agios, Bristol-Myers Squibb, Celgene, Clovis, Cornerstone, Exelixis, Fibrogen, Incyte, Ipsen, Medimmune, NCI, Relay, Repare, Syros, and Beigene; travel compensation from ASCO, Cholangiocarcinoma Foundation, and Lynx Group. W. Abidi: Consultant for Ambu Inc, Apollo Endosurgery US Inc, and ConMed Corporation; research support from GI Dynamics; food and beverage compensation from Ambu Inc, Apollo Endosurgery US Inc, ConMed Corporation, Olympus America Inc, AbbVie Inc, Boston Scientific Corporation, RedHill Biopharma Inc, and Salix Pharmaceuticals. S. K. Amateau: Consultant for Boston Scientific Corporation, Merit Medical, Olympus Corporation of the Americas, MTEndoscopy, US Endoscopy, Heraeus Medical Components, LLC, and Cook Medical LLC; travel compensation from Boston Scientific Corporation; food and beverage compensation from Boston Scientific Corporation, Olympus Corporation of the Americas, and Cook Medical LLC; advisory board for Merit Medical. N. Coelho-Prabhu: Consultant for Boston Scientific Corporation and Alexion Pharma; research support from Cook Endoscopy and Fujifilm; food and beverage compensation from Olympus America Inc and Boston Scientific Corporation. N. Cosgrove: Consultant for Olympus Corporation of the Americas and Boston Scientific Corporation; food and beverage compensation from Boston Scientific Corporation and Ambu Inc. S. E. Elhanafi: Food and beverage compensation from Medtronic, Inc, Nestle HealthCare Nutrition Inc, Ambu Inc, Salix Pharmaceuticals, Takeda Pharmaceuticals USA, Inc, and Merit Medical Systems Inc. L. L. Fujii-Lau: Food and beverage compensation from Pfizer Inc and AbbVie Inc. D. R. Kohli: Research grant from Olympus Corporation of the Americas. N. B. Marya: Consultant for Boston Scientific Corporation; food and beverage compensation from Boston Scientific Corporation and Apollo Endosurgery US Inc. S. Pawa: Consultant for Boston Scientific Corporation. N. R. Thiruvengadam: Received support from Boston Scientific Corporation. N. C. Thosani: Consultant for Pentax of America, Inc, Boston Scientific Corporation, and Ambu Inc; travel compensation Pentax of America, Inc, Boston Scientific Corporation, and AbbVie Inc; food and beverage compensation from Pentax of America, Inc, Boston Scientific Corporation, and AbbVie Inc; speaker for AbbVie Inc. B. J. Qumseya: Consultant for Medtronic, Inc and Assertio Management, LLC; food and beverage compensation from Medtronic, Inc, Fujifilm Healthcare Americas Corporation, and Boston Scientific Corporation; speaker for Castle Biosciences.
(Copyright © 2024 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: